Literature DB >> 31599190

Association between cognitive impairment and cardiovascular burden in patients with severe mental disorder.

Quintí Foguet-Boreu1,2, Anna Guàrdia Sancho3,4, Jose Manuel Santos Lopez1, Pere Roura Poch1,5, Joan Palmarola Ginesta1, Anna Maria Puig-Ribera3, Jordina Muñoz Pradós1.   

Abstract

Introduction: Cognitive impairment is related to an increase in cardiovascular risk (CVR) in the general population. However, in severe mental disorder (SMD), the evidence is less consistent. Few studies have evaluated the relationship between cognition and vascular burden in SMD. This study determines the relationship between cognition and vascular burden in patients with SMD.
Methods: Sixty SMD patients (61% men, mean age: 46) attending a psychosocial rehabilitation centre were included. We evaluated sociodemographic, clinical, laboratory, quality of life and functionality characteristics. And we analysed the association between cognitive performance and vascular burden.
Results: SMD diagnoses were: 41.7% schizophrenia, 20.0% bipolar, 5.0% schizoaffective, 21.7% depressive and 11.7% other. Cognitive impairment was present in 55% of the cases. The average vascular burden was 3.2. Patients with cognitive impairment have a significantly higher vascular burden than patients without cognitive impairment (p < 0.05). The speed of processing had a moderate correlation with vascular burden (r = -0.457, p = 0.001).Conclusions: Patients with cognitive impairment had a significantly higher vascular burden than patients without cognitive impairment. There are two practical clinical implications: CVR should be evaluated in all SMD patients; and psychoeducation programmes for CVR should be performed and adapted to the cognitive deficits.

Entities:  

Keywords:  Cognition; cardiovascular risk; cognitive impairment; severe mental disorder; vascular burden

Mesh:

Year:  2019        PMID: 31599190     DOI: 10.1080/13546805.2019.1676709

Source DB:  PubMed          Journal:  Cogn Neuropsychiatry        ISSN: 1354-6805            Impact factor:   1.871


  3 in total

1.  Impact of polygenic risk for coronary artery disease and cardiovascular medication burden on cognitive impairment in psychotic disorders.

Authors:  Lusi Zhang; Scot Kristian Hill; Bin Guo; Baolin Wu; Ney Alliey-Rodriguez; Seenae Eum; Paulo Lizano; Elena I Ivleva; James L Reilly; Richard S E Keefe; Sarah K Keedy; Carol A Tamminga; Godfrey D Pearlson; Brett A Clementz; Matcheri S Keshavan; Elliot S Gershon; John A Sweeney; Jeffrey R Bishop
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2021-10-29       Impact factor: 5.067

2.  Prevalence, Influencing Factors, and Clinical Characteristics of Cognitive Impairment in Elderly Patients With Schizophrenia.

Authors:  Guojun Liu; Xiaoying Zhang; Xiaoning Huo; Wei Li
Journal:  Front Psychiatry       Date:  2022-06-06       Impact factor: 5.435

3.  How to improve the physical health of people with severe mental illness? A multicentric randomized controlled trial on the efficacy of a lifestyle group intervention.

Authors:  Mario Luciano; Gaia Sampogna; Mario Amore; Ileana Andriola; Pietro Calcagno; Claudia Carmassi; Valeria Del Vecchio; Liliana Dell'Osso; Giorgio Di Lorenzo; Barbara Gelao; Vincenzo Giallonardo; Alessandro Rossi; Rodolfo Rossi; Alberto Siracusano; Andrea Fiorillo
Journal:  Eur Psychiatry       Date:  2021-11-23       Impact factor: 5.361

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.